Skip to content
BidBenchmark

Contract award

ZYDUS PHARMACEUTICALS (USA) INC.

NEW AWARD FOR DPP-4 SITAGLIPTIN WITH ZYDUS PHARMACEUTICALS (USA)INC. PERIOD OF PERFORMANCE IS 5/18/2024 - 5/17/2025 WITH FOUR ONE-YEAR OPTION PERIODS.
PIID
36E79724D0021
Award key
CONT_IDV_36E79724D0021_3600
Recipient UEI
QMFQCPLJ9F36
Source as of
Current award value
3
Obligated to date
$02
Potential with options
$113,797,6203
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Set-aside
No set-aside used
Pricing
Firm Fixed Price
Competition
Full and Open Competition1 offers received
Period of performance
May 18, 2024May 17, 2027
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Mar 18, 2024Initial award$0.00
P00001Apr 4, 2024B$0.00
P00002Sep 18, 2024Y$0.00
P00003Oct 29, 2024B$0.00
P00004Nov 20, 2024B$0.00
P00005Apr 3, 2025Y$0.00
P00006Apr 17, 2025M$0.00
P00007Apr 22, 2025G$0.00
P00008Dec 8, 2025M$0.00
P00009Jan 14, 2026Y$0.00
P00010Apr 15, 2026G$0.00
P00011Sep 9, 2026B$0.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
contractor_idUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
current_award_valueUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
naics_codeUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
potential_award_valueUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
psc_codeUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d
total_obligatedUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f4680f46be7d

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 12 transaction records parsed from USAspending.gov, retrieved Sep 11, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36E79724D0021 — ZYDUS PHARMACEUTICALS (USA) INC. · BidBenchmark